Reporting owner · Q3 2026 · CIK 1993147

Evran Sedat: insider trades.

Evran Sedat reported 4 non-derivative transactions on 1 SEC ownership filings in Q3 2026: 0 open-market purchases and 0 sales, across 1 company.

Transactions
4
Purchases (P)
0
Sales (S)
0
Companies
1
Name as filed
EVRAN SEDAT

Companies

CompanyRelationshipTransactions
Bio-Rad Laboratories, Inc. (BIO)Officer · EVP, Global Supply Chain4

Transactions

4 non-derivative rows. Shares and prices as filed.
DateCompanyCodeSharesPriceOwned afterFiling
2026-09-06Bio-Rad Laboratories, Inc.F277$386.113,603Form 4
2026-09-06Bio-Rad Laboratories, Inc.M864$03,880Form 4
2026-09-05Bio-Rad Laboratories, Inc.F329$386.113,016Form 4
2026-09-05Bio-Rad Laboratories, Inc.M1,027$03,345Form 4

Questions

What stock did Evran Sedat buy or sell?

Evran Sedat reported 4 non-derivative transactions on 1 SEC ownership filings in Q3 2026: 0 open-market purchases and 0 sales, across 1 company.

Is Evran Sedat the same person as other filers with this name?

This page covers SEC CIK 1993147 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.

Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.

Plain-text version for agents and LLMs: /insiders/evran-sedat-1993147.md

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.